Search
for
Sort by
Research 781–810 of 1000+
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Incidental benefits after fecal microbiota transplant for ulcerative colitis
- Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?
- Characterization of X‐linked hypohidrotic ectodermal dysplasia (XL‐HED) hair and sweat gland phenotypes using phototrichogram analysis and live confocal imaging
- Efficacy of Korean Red Ginseng in the Treatment of Atopic Dermatitis
- Distribution of 1,25-dihydroxyvitamin D3[22-oxa] in vivo receptor binding in adult and developing skin
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Modulation of Photoaging-Induced Cutaneous Elastin: Evaluation of Gene and Protein Expression of Markers Related to Elastogenesis Under Different Photoexposure Conditions
- Oral medications for central serous chorioretinopathy: a literature review
- Mackerel-Derived Fermented Fish Oil Promotes Hair Growth by Anagen-Stimulating Pathways
- Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam
- Androgen Receptor (<i>AR</i>) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- A Novel Effect for Glycine on Root System Growth of Habanero Pepper
- Limited stage small cell lung cancer
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Label-free concurrent 5-modal microscopy (Co5M) resolves unknown spatio-temporal processes in wound healing
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women
- Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29
- Photostability and toxicity of finasteride, diclofenac and naproxen under simulating sunlight exposure: evaluation of the toxicity trend and of the packaging photoprotection
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.